These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1319 related items for PubMed ID: 18803984

  • 21. [Diabetic patients in the Yom Kippur fast--who can fast and how to treat the fasting patients].
    Katz Y, Zangen D, Leibowitz G, Szalalt A.
    Harefuah; 2009 Sep; 148(9):586-91, 659, 658. PubMed ID: 20070046
    [Abstract] [Full Text] [Related]

  • 22. Managing diabetes during the Muslim fasting month of Ramadan.
    Velayudhan M.
    Med J Malaysia; 2012 Jun; 67(3):353-4; quiz 355. PubMed ID: 23082439
    [Abstract] [Full Text] [Related]

  • 23. Type 2 diabetes mellitus--guidelines for initiating insulin therapy.
    Yeap BB.
    Aust Fam Physician; 2007 Jul; 36(7):549-53. PubMed ID: 17619673
    [Abstract] [Full Text] [Related]

  • 24. Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes.
    Vigeral C, Sola-Gazagnes A, Nejjar S, M'Bemba J, Boitard C, Slama G, Elgrably F, Larger E.
    Diabetes Metab; 2011 Dec; 37(6):553-9. PubMed ID: 21802332
    [Abstract] [Full Text] [Related]

  • 25. Comparison of analog insulin mix 50:50 with human insulin mix 30:70 in persons with type 2 diabetes during Ramadan.
    Hajjaji IM, Eshwihdi N, Barrowman N.
    Int J Clin Pract; 2019 Jun; 73(6):e13348. PubMed ID: 30912213
    [Abstract] [Full Text] [Related]

  • 26. Inhaled insulin: Exubera.
    Odegard PS, Capoccia KL.
    Ann Pharmacother; 2005 May; 39(5):843-53. PubMed ID: 15827072
    [Abstract] [Full Text] [Related]

  • 27. Refining basal insulin therapy: what have we learned in the age of analogues?
    Devries JH, Nattrass M, Pieber TR.
    Diabetes Metab Res Rev; 2007 Sep; 23(6):441-54. PubMed ID: 17668418
    [Abstract] [Full Text] [Related]

  • 28. Islamic fasting and health.
    Azizi F.
    Ann Nutr Metab; 2010 Sep; 56(4):273-82. PubMed ID: 20424438
    [Abstract] [Full Text] [Related]

  • 29. Insulin lispro (Lys(B28), Pro(B29) in the treatment of diabetes during the fasting month of Ramadan. Ramadan Study Group.
    Akram J, De Verga V.
    Diabet Med; 1999 Oct; 16(10):861-6. PubMed ID: 10547214
    [Abstract] [Full Text] [Related]

  • 30. Preoperative hypoglycemia in a patient receiving insulin detemir.
    Olson RP, Bethel MA, Lien L.
    Anesth Analg; 2009 Jun; 108(6):1836-8. PubMed ID: 19448209
    [Abstract] [Full Text] [Related]

  • 31. [Recommendations concerning the initial regimen and dose adjustments of insulin therapy for type 2 diabetes mellitus].
    Houweling ST, Timmerman GJ, Hoogstraten MF, Ubink-Veltmaat LJ, Verhoeven S, Bilo HJ.
    Ned Tijdschr Geneeskd; 2002 Sep 28; 146(39):1823-7. PubMed ID: 12382366
    [Abstract] [Full Text] [Related]

  • 32. Practices of Arab American patients with type 2 diabetes mellitus during Ramadan.
    Pinelli NR, Jaber LA.
    J Pharm Pract; 2011 Apr 28; 24(2):211-5. PubMed ID: 21712216
    [Abstract] [Full Text] [Related]

  • 33. Glycaemic Control Of Type 2 Diabetic Patients During Ramazan Fasting.
    Malik U, Mahmood N, Khan KA, Hameed M, Randhawa FA, Salman S, Riaz A, Waheed K, Rasheed A.
    J Ayub Med Coll Abbottabad; 2017 Apr 28; 29(1):102-106. PubMed ID: 28712186
    [Abstract] [Full Text] [Related]

  • 34. Lispro insulin in type 1 diabetic patients on a Mediterranean or normal diet: a randomized, cross-over comparative study with regular insulin.
    Provenzano C, Vero R, Oliva A, Leto G, Puccio L, Vecci E, Mattioli PL, Di Mario U.
    Diabetes Nutr Metab; 2001 Jun 28; 14(3):133-9. PubMed ID: 11476360
    [Abstract] [Full Text] [Related]

  • 35. A randomised controlled trial of insulin lispro given before or after meals in pregnant women with type 1 diabetes--the effect on glycaemic excursion.
    Carr KJ, Idama TO, Masson EA, Ellis K, Lindow SW.
    J Obstet Gynaecol; 2004 Jun 28; 24(4):382-6. PubMed ID: 15203576
    [Abstract] [Full Text] [Related]

  • 36. Safety and metabolic impact of Ramadan fasting in children and adolescents with type 1 diabetes.
    El-Hawary A, Salem N, Elsharkawy A, Metwali A, Wafa A, Chalaby N, El-Gilany A, Abo-Elmagd M, El-Ziny M.
    J Pediatr Endocrinol Metab; 2016 May 01; 29(5):533-41. PubMed ID: 26926864
    [Abstract] [Full Text] [Related]

  • 37. Diabetes and Ramadan: an update on use of glycemic therapies during fasting.
    Ahmed MH, Abdu TA.
    Ann Saudi Med; 2011 May 01; 31(4):402-6. PubMed ID: 21727749
    [Abstract] [Full Text] [Related]

  • 38. Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan.
    Hassanein M, Echtay AS, Malek R, Omar M, Shaikh SS, Ekelund M, Kaplan K, Kamaruddin NA.
    Diabetes Res Clin Pract; 2018 Jan 01; 135():218-226. PubMed ID: 29183844
    [Abstract] [Full Text] [Related]

  • 39. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.
    Khalil AB, Beshyah SA, Abu Awad SM, Benbarka MM, Haddad M, Al-Hassan D, Kahwatih M, Nagelkerke N.
    Diabetes Technol Ther; 2012 Sep 01; 14(9):813-8. PubMed ID: 22827507
    [Abstract] [Full Text] [Related]

  • 40. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan.
    Mattoo V, Milicevic Z, Malone JK, Schwarzenhofer M, Ekangaki A, Levitt LK, Liong LH, Rais N, Tounsi H, Ramadan Study Group.
    Diabetes Res Clin Pract; 2003 Feb 01; 59(2):137-43. PubMed ID: 12560163
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 66.